Cancer Stem Cells Market - (By Type - Blood Cancer, Breast Cancer, Brain Cancer, Skin Cancer, Colorectal Cancer; Market By End User - Oncology Center, Diagnostic & Research Laboratories) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

Cancer is a condition associated with the uncontrollable growth of the cell in the body. Over 100 types of cancer are observed in the human body. Stem cells are cells which are required for the maintenance of healthy tissue, where cells continually been replaced. They are undifferentiated cells and thus has got a huge application in the treatment of the various diseases. A number of different types treatment are used in the cure of cancer however, stem cell is expected to be one of the most prominent therapy for the treatment with minimal side effects. Many major pharmaceutical and research organization are trying to introduce new and advanced treatment options.

Market Dynamics

The major driving factors for the market are increasing prevalence of cancer, increasing need for the better treatment and increasing government support. According to American Cancer Society, about 1.7 million new cancer cases are expected to be diagnosed by the end of 2018 and approximately 609,640 Americans are expected to die of cancer in 2018 i.e. 1,670 deaths per day. Increasing spending on research and development has boosted the growth of the market. Cancer Research UK have spent USD 518 million on cancer research across the U.K to accelerate progress and increase cancer surviving rate by 75% by 2034. The organization is also aiming to increase the proportion of GDP spend on R&D to 2.6% by 2023. Additionally, increasing per capita income of the people, favorable reimbursement policies, and increasing awareness about availability of treatment have supported the growth of market.

However, availability of the alternative treatment may slow the growth of the market.

Market Classification and Overview

The global cancer stem cells market is segmented into types, end users, and region.

On the basis of types, the market is segmented into breast cancer, blood cancer, brain cancer, colorectal cancer, skin cancer, and others.

Based on the end users, the market is segmented into oncology center, diagnostic & research laboratories, and others.

Regional Overview

Geographically, the global cancer stem cells market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is one of the leading markets across the globe owing to high prevalence of various cancers in region including lung cancer and breast cancer, and ovarian cancer, among others. According to the American Cancer Society, in 2016, over 15.5 million people survived of cancer and the number is expected to reach 20.3 million by 2026 in the U.S.  Additionally, to meet the upcoming demand and grab the major share of the market, most of the key players are heavily investing in research and development activities and using modern technologies in R&D in this region which has supported the growth of the market.

Increasing government support and growing expenditure on R&D are projected to drive the Europe cancer stem cell market. France and Germany are the largest contributors to Europe market growth owing to increasing investments in health care and cancer research. Asia Pacific is the fastest growing region. However, Latin American and the Middle Eastern countries including Saudi Arabia, United Arab Emirates (UAE), and Kuwait are projected to drive the LAMEA market as result of increasing demand for specialty care services and growing healthcare sector.  On the other hand, Africa is estimated to witness moderate growth.

Report Coverage

Market

Cancer Stem Cells Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, End-Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

The cancer stem cells market comprises of some of the major players such as

  • Celula, Inc.
  • AdnaGen GmbH
  • Epic Sciences, Inc.
  • AVIVA Biosciences Corporation
  • Fluxion Biosciences, Inc.
  • Rarecells USA, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Silicon Biosystems, S.p.A.
  • Others

Market Segmentation

Market By Type

  • Blood Cancer
  • Breast Cancer
  • Brain Cancer
  • Skin Cancer
  • Colorectal Cancer
  • Others

Market By End-User

  • Oncology Center
  • Diagnostic & Research Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary